Cardiovascular Prevention and Pharmacotherapy最新文献

筛选
英文 中文
Perioperative Management of Hypertensive Patients 高血压患者围手术期的处理
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2021-07-01 DOI: 10.36011/cpp.2021.3.e7
Helsi Rismiati, Hae-Young Lee
{"title":"Perioperative Management of Hypertensive Patients","authors":"Helsi Rismiati, Hae-Young Lee","doi":"10.36011/cpp.2021.3.e7","DOIUrl":"https://doi.org/10.36011/cpp.2021.3.e7","url":null,"abstract":"","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133037745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of Patients with Vasospastic Angina in Korea: Data from a Large Cohort (VA-KOREA) 韩国血管痉挛性心绞痛患者的特征:来自大队列的数据(VA-KOREA)
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2021-07-01 DOI: 10.36011/cpp.2021.3.e8
Sung Eun Kim, S. Jo, W. Seo, Min-Ho Lee, Hyun-Jin Kim, Seong-Sik Cho, K. Lee, Dong-Soo Kim, Tae-Hyun Yang, S. Her, S. Han, Byoung-Kwon Lee, Youngkeun Ahn, S. Rha, H. Gwon, D. Choi, S. Baek
{"title":"Characteristics of Patients with Vasospastic Angina in Korea: Data from a Large Cohort (VA-KOREA)","authors":"Sung Eun Kim, S. Jo, W. Seo, Min-Ho Lee, Hyun-Jin Kim, Seong-Sik Cho, K. Lee, Dong-Soo Kim, Tae-Hyun Yang, S. Her, S. Han, Byoung-Kwon Lee, Youngkeun Ahn, S. Rha, H. Gwon, D. Choi, S. Baek","doi":"10.36011/cpp.2021.3.e8","DOIUrl":"https://doi.org/10.36011/cpp.2021.3.e8","url":null,"abstract":"","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127182966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers in Salt Reduction Strategies: Time to Acting for the Future 减盐战略中的障碍:是时候为未来采取行动了
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2020-10-01 DOI: 10.36011/cpp.2020.2.e16
Yong-Jae Kim
{"title":"Barriers in Salt Reduction Strategies: Time to Acting for the Future","authors":"Yong-Jae Kim","doi":"10.36011/cpp.2020.2.e16","DOIUrl":"https://doi.org/10.36011/cpp.2020.2.e16","url":null,"abstract":"Salt reduction is important for reducing hypertension and the risk of cardiovascular events and stroke. Despite knowledge about the ill consequences, many people continue to consume high levels of salt in their diet. This paper introduces salt-reducing programs for individual, population, and country-level strategies to reduce salt intake. To effectively decrease salt intake, it is necessary to reduce the consumption of high-salt foods and replace high-salt seasonings with low-salt alternatives. Thus, healthcare professionals must effectively provide information on salt-reduction for patients with hypertension. Social strategies, such as voluntary sodium reduction targets for the food industry, are necessary to promote population strategies for salt reduction. In this paper, we examine a brief report on new salt intake values based on chronic disease risk reduction and explain the utilization of mobile health technologies to reduce salt consumption. Considering the relationship between dietary salt intake and the risk of chronic disease, ways to remove the barriers to strategies for salt reduction should be considered, as it is the most effective way for the prevention and control of hypertension and cardiovascular disease in the future.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133538521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Causal Claims in Health Sciences and Medicine: a Difference-in-Differences Method 健康科学和医学中的因果主张:差异中的差异方法
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2020-07-01 DOI: 10.36011/cpp.2020.2.e13
Kyoung-Nam Kim
{"title":"Causal Claims in Health Sciences and Medicine: a Difference-in-Differences Method","authors":"Kyoung-Nam Kim","doi":"10.36011/cpp.2020.2.e13","DOIUrl":"https://doi.org/10.36011/cpp.2020.2.e13","url":null,"abstract":"The difference-in-differences (DID) method is a useful tool to make causal claims using observational data. The key idea is to compare the difference between exposure and control groups before and after an event. The potential outcome of the exposure group during the post-exposure period is estimated by adding the observed outcome change of the control group between the pre- and post-exposure period to the observed outcome of the exposure group during the pre-exposure period. Because the effect of exposure is evaluated by comparing the observed outcome and potential outcome of the same exposure group, unmeasured potential confounders can be cancelled out by the design. To apply this method appropriately, the difference between the exposure and control groups needs to be relatively stable if no exposure occurred. Despite the strengths of the DID method, the assumptions, such as parallel trends and proper comparison groups, need to be carefully considered before application. If used properly, this method can be a useful tool for epidemiologists and clinicians to make causal claims with observational data.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126590157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevention of Type 2 Diabetes 预防2型糖尿病
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2020-07-01 DOI: 10.36011/cpp.2020.2.e10
Jong Dai Kim, Won-Young Lee
{"title":"Prevention of Type 2 Diabetes","authors":"Jong Dai Kim, Won-Young Lee","doi":"10.36011/cpp.2020.2.e10","DOIUrl":"https://doi.org/10.36011/cpp.2020.2.e10","url":null,"abstract":"","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126994703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shifting from Pharmacotherapy to Prevention of Hypertension 从药物治疗转向高血压预防
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2020-04-01 DOI: 10.36011/cpp.2020.2.e8
B. Cheung, M. Tsoi
{"title":"Shifting from Pharmacotherapy to Prevention of Hypertension","authors":"B. Cheung, M. Tsoi","doi":"10.36011/cpp.2020.2.e8","DOIUrl":"https://doi.org/10.36011/cpp.2020.2.e8","url":null,"abstract":"Hypertension is a common chronic disease affecting a large section of the general population. As hypertension is usually asymptomatic, awareness, treatment and control rates are low. Drug side-effects also affect compliance. Hypotension and electrolyte abnormalities in the elderly can be severe. Therefore, prevention is better than cure. As blood pressure rises with age, prevention should be started early. As there are many genes affecting blood pressure, genetic tests are not useful. Good antenatal care and care of preterm infants can help to prevent adult cardiovascular diseases including hypertension. Childhood obesity is an important determinant of blood pressure in childhood and adolescence. This is a window of opportunity for prevention. The current American College of Cardiology/American Heart Association guideline on hypertension defines stage 1 hypertension as a systolic blood pressure of 130–139 mmHg or a diastolic blood pressure of 80–89 mmHg. Although this makes many people in the general population hypertensive, stage 1 hypertension in young adults is already associated with increased cardiovascular and mortality risk. Fortunately, hypertension at this early stage is easy to control and weight loss is easier in young males, who can get exercise from work or exercise after work. Leisure-time physical activity seems more beneficial than occupational physical activity. Cardiovascular risk assessment and promoting a healthy lifestyle in the young are likely to forestall hypertension and future cardiovascular disease. Preventing or reversing hypertension is no longer an impossible dream.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"697 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126458008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Recent Technology-Driven Advancements in Cardiovascular Disease Prevention in Korea 韩国心血管疾病预防的最新技术进展
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2019-10-01 DOI: 10.36011/cpp.2019.1.e7
Jisan Lee, Hun‐Sung Kim, Dai-Jin Kim
{"title":"Recent Technology-Driven Advancements in Cardiovascular Disease Prevention in Korea","authors":"Jisan Lee, Hun‐Sung Kim, Dai-Jin Kim","doi":"10.36011/cpp.2019.1.e7","DOIUrl":"https://doi.org/10.36011/cpp.2019.1.e7","url":null,"abstract":"Recent dramatic developments in information and communication technologies have been widely applied to medicine and healthcare. In particular, biometric sensors in wearable devices linked to smartphones are collecting vast amounts of personal health data. To best use these accumulated data, personalized healthcare services are emerging, and digital platforms are being developed and studied to enable data integration and analysis. The implementation of biometric sensors and smartphones for cardiovascular and cerebrovascular healthcare emerged from the research on the feasibility and efficacy of the devices in the clinical environment. It is important to understand the recent research trends in data generation, integration, and application to prevent and treat cardiovascular and cerebrovascular diseases. This paper describes these recent developments in treating cardiovascular diseases.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123547984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Improving Causal Inference in Observational Studies: Propensity Score Matching 改善观察性研究中的因果推断:倾向评分匹配
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2019-10-01 DOI: 10.36011/cpp.2019.1.e6
M. Yu, D. Kang
{"title":"Improving Causal Inference in Observational Studies: Propensity Score Matching","authors":"M. Yu, D. Kang","doi":"10.36011/cpp.2019.1.e6","DOIUrl":"https://doi.org/10.36011/cpp.2019.1.e6","url":null,"abstract":"Propensity score matching (PSM) is a useful statistical methods to improve causal inference in observational studies. It guarantees comparability between 2 comparison groups are required. PSM is based on a “counterfactual” framework, where a causal effect on study participants (factual) and assumed participants (counterfactual) are compared. All participants are divided into 2 groups with the same covariates matched as much as possible. Propensity score is used for matching, and it reflects the conditional probabilities that individuals will be included in the experimental group when covariates are controlled for all subjects. The counterfactuals for the experimental group are matched between groups with characteristics as similar as possible. In this article, we introduce the concept of PSM, PSM methods, limitations, and statistical tools.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124790699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
CYP2C19 Polymorphisms and Smoking Status Affects Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel CYP2C19多态性和吸烟状况影响对血小板P2Y12受体拮抗剂氯吡格雷的反应性
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2019-10-01 DOI: 10.36011/cpp.2019.1.e8
Sang-Won Han, Yong-Jae Kim, W. Seo, S. Yu, H. Nam, S. Yoon, S. H. Kim, J. Lee, Jun Hong Lee, Yang-Ha Hwang, Jun Lee, Kyung-A Lee, Kyung-Yul Lee
{"title":"CYP2C19 Polymorphisms and Smoking Status Affects Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel","authors":"Sang-Won Han, Yong-Jae Kim, W. Seo, S. Yu, H. Nam, S. Yoon, S. H. Kim, J. Lee, Jun Hong Lee, Yang-Ha Hwang, Jun Lee, Kyung-A Lee, Kyung-Yul Lee","doi":"10.36011/cpp.2019.1.e8","DOIUrl":"https://doi.org/10.36011/cpp.2019.1.e8","url":null,"abstract":"","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114344930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pregnancy at Late Maternal Age and Future Cardiovascular Health 高龄产妇妊娠与未来心血管健康
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2019-10-01 DOI: 10.36011/cpp.2019.1.e9
Mi-Jeong Kim
{"title":"Pregnancy at Late Maternal Age and Future Cardiovascular Health","authors":"Mi-Jeong Kim","doi":"10.36011/cpp.2019.1.e9","DOIUrl":"https://doi.org/10.36011/cpp.2019.1.e9","url":null,"abstract":"Increasing numbers of women are delivering their first child at a later age. First pregnancy at a later age is, per se, a high-risk pregnancy. Pregnancy after 35 years is traditionally considered a late maternal age. The risks of obstetric complications including fetal and maternal complications are increased. Defective placenta syndrome, including hypertensive disorders, preterm birth, and intrauterine growth retardation, shares similar pathophysiologic mechanisms with endothelial dysfunction, although their clinical presentations differ. Recent medical advances have improved the medical performance of pregnancy-related cardiovascular disease (CVD). Recent evidence has shown that women with underlying defective placental syndrome or other pregnancy-related complications have an increased risk of unfavorable cardiovascular outcomes in later life. An increasing number of women delivering their first child at a later age have epidemiological characteristics that differ from those reported previously and for which data are limited data regarding the cardiovascular prognosis. Therefore, increased attention to public health and CVD prevention is required for women with complicated pregnancies.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125585238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书